Fingolimod Capsule
Product Images NDC 64980-449

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Fingolimod (NDC 64980-449). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Fingolimod 01)

Chemical structure of Fingolimod hydrochloride showing its molecular arrangement with a long hydrocarbon chain, a phenyl ring, and functional groups including hydroxyl and ammonium chloride moieties.*

FDA Label Image

Figure 1 (Fingolimod 02)

A line graph comparing the percentage of patients with three-month confirmed progression over time (days) between Fingolimod 0.5 mg and placebo groups. The x-axis shows time in days up to 720, and the y-axis shows the percentage from 0 to 30%. The Fingolimod group is represented by a solid red line, reaching 18%, and the placebo group by a dashed black line, reaching 24%.*

FDA Label Image

Carton 28 (Fingolimod 03)

Fingolimod Capsules 0.5 mg oral capsules packaging label from Rising Pharma Holdings, Inc. The label indicates a 28-count supply, doses equivalent to 0.56 mg fingolimod hydrochloride, and includes directions for pharmacists to dispense the enclosed medication guide. The label also provides storage instructions and manufacturer information from Sunshine Lake Pharma Co., Ltd. in China.*

FDA Label Image

Bottle30 (Fingolimod 04)

Label for Fingolimod Capsules 0.5 mg by Rising Pharmaceuticals, showing a package containing 30 capsules. The label includes dosage information, storage instructions, and distributor details as Rising Pharmaceuticals, Inc. and manufacturer details from Sunshine Lake Pharma Co., Ltd., Guangdong Province, China.*

FDA Label Image

Carton 7 (Fingolimod 05)

Fingolimod capsules 0.5 mg packaging label by Rising Pharma Holdings, Inc. The label indicates each capsule contains 0.5 mg fingolimod, equivalent to 0.56 mg fingolimod hydrochloride, and includes 7 capsules per package. The label notes storage instructions, pharmacist dispensing guidance for the enclosed Medication Guide, and that the product is Rx only. Manufactured by Sunshine Lake Pharma Co., Ltd. in China and distributed by Rising Pharmaceuticals, Inc.*

FDA Label Image

Heclogo2 (Logo0001)

FDA Label Image

Risinglogo2 (Logo0002)

The image shows a blister card containing 10 white capsules of fingolimod 0.5 mg. This oral capsule packaging is labeled with the product name fingolimod and the active ingredient Fingolimod HCl. The labeler is Rising Pharma Holdings, Inc. The product NDC is 64980-449. The capsules are arranged in two rows of five.*

FDA Label Image

Logo0003

FDA Label Image

Logo0004

Fingolimod 0.5 mg oral capsule carton from Rising Pharma Holdings, Inc. The front of the box displays the product name, strength, dosage form, with a package size of 30 capsules. The label includes standard regulatory information and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.